Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Prospective Multicentre Study of the Use of Ketamine in the Treatment of Refractory Chronic Pain in the French CLCC
Centre Leon Berard
Pharmacogenetics Associated With IV Ketamine
Brain and Cognition Discovery Foundation
Ketamine for Pain Control After Severe Traumatic Injury
Medical College of Wisconsin
Inpatient Single Dose Interventions for Alcohol Use Disorder
Denver Health and Hospital Authority
Phase 1 Evaluation of (2R,6R)-Hydroxynorketamine
National Institute of Mental Health (NIMH)
Music as an Intervention to Improve Hemodynamic Tolerability of Ketamine in Depression
Douglas Mental Health University Institute
Analgesic Efficacy of Orally Administered VTS-K for Pain Management
Antonios Likourezos
Cardiac Index and General Anesthesia Without Opioid.
Centre Hospitalier de Montauban
Effects of MDMA Co-administration on the Response to LSD in Healthy Subjects
University Hospital, Basel, Switzerland
The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density
Section for Affective Disorders; Northern Stockholm Psychiatry
A Study of SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Suicide
Seelos Therapeutics, Inc.
Ketamine for the Treatment of Opioid Use Disorder and Depression
Medical University of South Carolina
Neurodynamics of Prosocial Emotional Processing Following Serotonergic Stimulation With N,N-Dimethyltryptamine (DMT) and Harmine in Healthy Subjects
Psychiatric University Hospital, Zurich
A Study in Healthy Men to Test Whether BI 409306, BI 425809 or Lamotrigine Can Reverse the Memory Problems Caused by Ketamine
Boehringer Ingelheim
Relative Bioavailability Study of MELT-100, IV Midazolam, and IV Ketamine
Melt Pharmaceuticals
Characteristics, Adherence, and Persistence Among Multiple Sclerosis Patients Treated With Disease-Modifying Therapies
Novartis
The Ketamine for Acute Postoperative Analgesia (KAPA) Trial
University Health Network, Toronto
Ketamine to Prevent PPD After Cesarean
Washington University School of Medicine
Pro-inflammatory Role of Blood Platelets in Critically Ill Patients With Septic Shock.
University Hospital, Bordeaux
A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression
Janssen Research & Development, LLC
Preliminary Efficacy and Safety of Ibogaine in the Treatment of Methadone Detoxification
International Center for Ethnobotanical Education, Research, and Service
Ketamine for Older Adults Pilot
Washington University School of Medicine
Effect of Ketanserin After LSD Administration
University Hospital, Basel, Switzerland
Ketamine Treatment Effects on Synaptic Plasticity in Depression
New York State Psychiatric Institute
Duration of Anaesthesia Induction in Paediatric Patients: Prospective Observational Trial
Brno University Hospital
Sodium Lactate and Brain Relaxation (LSD)
Centre Hospitalier Universitaire de Besancon
Intraoperative Ketamine for Patients Undergoing Total Joint Arthroplasty
Dartmouth-Hitchcock Medical Center
A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2)
Lykos Therapeutics
Efficacy of Ketamine in Post Anesthesia Recovery Room
University of Alberta
A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major Depressive Disorder
Janssen-Cilag International NV
Low-Dose Ketamine in Children With ADNP Syndrome
Alexander Kolevzon
Behavioral and Electrophysiological Effects of Ketamine in Treatment-Resistant Depression
Mclean Hospital
The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression
COMPASS Pathways
Long Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU)
COMPASS Pathways
Phase 1 Bioavailability Study of MELT-100 (Midazolam and Ketamine Sublingual) and IV Midazolam or Ketamine
Melt Pharmaceuticals
Characterization of Altered Waking States of Consciousness in Healthy Humans
University of Zurich
Ketamine for Acute Pain Management After Trauma
The University of Texas Health Science Center, Houston
Low Dose Ketamine and Acute Pain Crisis
Rhode Island Hospital
Open Label Study of MDMA-assisted Psychotherapy for Treatment of PTSD With Optional fMRI Sub-Study
MAPS Europe B.V.
Recovery After Total Intravenous Anesthesia With Ketofol Versus Mixture of Ketofol and Lidocaine for Short Pediatric Surgery
University Hospital of Split
A Study of Different Oral Thin Film (S)-Ketamine Formulations for Sublingual Administration in Healthy Participants
Janssen Research & Development, LLC
Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients
University of Zurich
Comparative Acute Effects of LSD, Psilocybin and Mescaline
University Hospital, Basel, Switzerland
Impact of Fingolimod Adherence on Outcomes
Novartis Pharmaceuticals
A Retrospective Effectiveness Trial of Ketamine-Assisted Psychotherapy in Adult Patients Coping With Mental Health
Field Trip Health
Ketamine-Induced Brain Changes and Their Modulation by Lamotrigine
Charite University, Berlin, Germany
A Study of Sublingually Administered (S)-Ketamine Oral Solution in Healthy Participants
Janssen Research & Development, LLC
Patient Doctor Lies
University of Utah
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.